marketing@medicilon.com
Preclinical Research Services- Quick start experiments and our flexible experimental design help you to speed up your decisions and lower your research cost.Medicilon's Preclinical Research Division services include toxicology, pharmacology and efficacy studies, absorption, distribution, metabolism, and excretion (ADME), drug metabolism and pharmacokinetics (DMPK), as well as bioanalytical solutions for small molecules, biologics, and natural products.
Complete Preclinical Research Laboratories- Medicilon's labs are certified by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) and comply with the GLP standards of the US FDA and NMPA agencies. Our preclinical safety experiments also comply with the Organization for Economic Cooperation and Development in Europe (OECD) GLP requirements.We maintain a large in-house library of animal disease models to meet the research demands of diverse therapeutic areas. Medicilon can also assist clients in the preparation of a preclinical safety evaluation package.
Certification- Medicilon offers preclinical animal testing service for the global pharmaceutical market. Technologies provided by Medicilon such as Drugs Safety Evaluation for Non-Human Primates Services Platform and Isotope Drug Metabolism Professional Services Platform are certified by the Shanghai government. In addition, our platform is certified and identified as an important drug discovery platform by the Shanghai government.
Medicilon’s Advantages- Extensive pharmaceutical drug discovery and development expertise in small molecules (NCE), biologics, and natural products for all therapeutic modalities Full AAALAC accredited laboratories and facilities400+ oncology models and 230+ non-tumor disease models for safety and efficacy assessmentA full range of bioanalytical services and global regulatory affairs to enable successful IND submissionIT platforms such as Watson LIMS software and Provantis ensure seamless data sharing, submission (SEND format), and securityDedicated research scientists with flexible capacity provide a high quality and cost efficient service
Service Cases
Medicilon Assists | China's First CD19×CD3×CD28 Trispecific Antibody Obtained FDA Implicit Approval
Medicilon Assistant| Jimincare's lgE Antibody Drug JYB1904 has been Approved for Clinical Trials
For more service cases, please contact us:
